Bank7 Corp. filings document the reporting obligations of a Nasdaq-listed bank holding company for Bank7. Current reports on Form 8-K furnish quarterly earnings releases and investor presentation materials covering results of operations, financial condition, liquidity, credit quality, capital ratios, and related Regulation FD disclosures.
Proxy materials describe annual meeting matters, shareholder voting procedures, board governance, and related shareholder communications. Other filings include Form 12b-25 notices for annual-report timing and exhibits that support the company’s public financial communications.
BSVN filed a notice of proposed sale of common stock under Rule 144. The person for whose account the securities are to be sold plans to sell 4,500 shares of common stock through Stifel Nicolaus & Company Inc. on or about 02/04/2026 on Nasdaq, with an aggregate market value of $204,750.00. The filing notes that 9,453,390 shares of this class were outstanding. The 4,500 shares were acquired on 09/20/2022 as restricted stock units from the issuer as equity compensation, with payment also dated 09/20/2022. By signing, the seller represents they do not know any material adverse, non-public information about the issuer’s current or prospective operations.
Bank7 Corp., the holding company for Bank7, issued a press release announcing its results of operations and financial condition for the quarter ended December 31, 2025. The release, which also covers fourth quarter and full year 2025 performance, is attached as Exhibit 99.1.
The company is hosting a conference call on January 15, 2026 at 9:00 a.m. CST to discuss these results, with presentation slides provided as Exhibit 99.2. The information in this report and its exhibits is furnished rather than filed under securities law.
Bank7 Corp. reported third‑quarter results. Net income was $10.8 million, and diluted EPS was $1.13 for the three months ended September 30, 2025. Net interest income rose to $23.0 million with a $0.7 million provision for credit losses, while noninterest income was $2.2 million and noninterest expense was $10.4 million.
Total assets reached $1.89 billion, up from $1.74 billion at December 31, 2024. Loans, net, increased to $1.51 billion from $1.38 billion, and deposits grew to $1.64 billion from $1.52 billion. The allowance for credit losses increased to $19.4 million. Nonaccrual loans were $5.3 million, down from $7.2 million at year‑end.
The company remained well capitalized, with a CET1 ratio of 14.22% and a Tier 1 leverage ratio of 12.71% as of September 30, 2025. For the nine months, net income was $32.3 million and diluted EPS was $3.38. The repurchase plan authorized up to 750,000 shares, with no repurchases during the period.
Bank7 Corp. (BSVN) insider filing: the company’s Regional President – Tulsa reported a Form 4 transaction dated 10/30/2025. Table I shows a common stock entry with transaction code F for 291 shares at $41.64, resulting in 47,088 shares beneficially owned, held directly.
Beneficial ownership includes restricted stock units: 3,000 RSUs vesting on February 15, 2026–2029; 3,750 RSUs from an original 5,000 grant vesting on February 15, 2025–2028; 18,750 RSUs from an original 25,000 grant vesting on February 15, 2024–2031; and 1,125 RSUs from an original 4,500 grant vesting on December 17, 2022–2025.
Bank7 Corp. (BSVN) furnished materials related to its third quarter performance. The company issued a press release announcing results for the quarter ended September 30, 2025 and provided investor presentation slides, each incorporated by reference as Exhibits 99.1 and 99.2.
The company will host a conference call on October 15, 2025 at 9:00 am CST to discuss Q3 2025 financial results. In line with General Instruction B.2, the information, including Exhibits 99.1 and 99.2, is furnished and not deemed filed under the Exchange Act.
Bank7 Corp. (BSVN) Form 4: Kelly J. Harris, Executive Vice President and Chief Financial Officer, reported open-market sales of the issuer's common stock on 09/02/2025 and 09/03/2025. On 09/02/2025 he sold 1,688 shares at a weighted-average price of $49.2795, reducing his beneficial ownership to 20,895 shares. On 09/03/2025 he sold 3,312 shares at a weighted-average price of $48.383, reducing his beneficial ownership to 17,583 shares. Holdings include multiple restricted stock unit grants with staggered vesting through 2028.
Bank7 Corp. (BSVN) Form 144 filing: An individual notified intent to sell 5,000 shares of Bank7 common stock on 09/02/2025 through Stifel Nicolaus. The reported aggregate market value of the proposed sale is $246,398.00. The filer states the shares were acquired as Restricted Stock Units on 09/20/2022, totaling 6,523 units, with cash used for payment on the acquisition date. The issuer has 9,450,979 shares outstanding per the form. No sales by the filer in the prior three months were reported.
Travis Thomas L, President & CEO and director of Bank7 Corp. (BSVN), reported a sale of 13,084 shares of common stock on 08/26/2025 at a weighted-average price of $49.3566. After the sale, he beneficially owns 286,293 shares. The filing notes that the sale occurred in multiple transactions with prices ranging from $49.16 to $49.55. The reported holdings include several restricted stock unit (RSU) balances that vest on specified future dates, with detailed vesting schedules disclosed for multiple grants. No derivative transactions were reported.
Form 144 notice for Bank7 Corp. (BSVN) records a proposed sale of 13,084 shares of common stock through Stifel Nicolaus & Company Inc. with an aggregate market value of $645,782.00. The filing lists 9,450,979 shares outstanding for the issuer and an approximate sale date of 08/26/2025 on the Nasdaq. The shares were acquired as Restricted Stock Units from the issuer on 09/21/2021, with 65,500 units originally acquired and payment noted as cash on the acquisition date. The filer reports no securities sold in the past three months and includes the standard attestation that no undisclosed material adverse information is known.